{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:52:36Z","timestamp":1791215556073,"version":"4.1.0"},"reference-count":95,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.2459\/jcm.0b013e32834058d1","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T02:57:35Z","timestamp":1287543455000},"page":"76-84","source":"Crossref","is-referenced-by-count":63,"title":["Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure"],"prefix":"10.2459","volume":"12","author":[{"given":"Marco","family":"Metra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Zac\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bonadies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra Dei","family":"Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Lagioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Maio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Magr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Padeletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pezzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Piepoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Zanolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savina","family":"Nodari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Perrone","family":"Filardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livio","family":"Dei Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210207","first-page":"e21","article-title":"Heart disease and stroke statistics: 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"R3-2-20210207","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","article-title":"2009 Focused update incorporated into the ACC\/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation","volume":"53","author":"Hunt","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R4-2-20210207","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"key":"R5-2-20210207","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","article-title":"Acute heart failure syndromes","volume":"53","author":"Gheorghiade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R6-2-20210207","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R7-2-20210207","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/eurheartj\/ehp024","article-title":"Treatment of heart failure in the elderly: never say it's too late","volume":"30","author":"Metra","year":"2009","journal-title":"Eur Heart J"},{"key":"R8-2-20210207","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"R9-2-20210207","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R10-2-20210207","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.","volume":"325","year":"1991","journal-title":"N Engl J Med"},{"key":"R11-2-20210207","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-2-20210207","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/eurheartj\/ehm605","article-title":"Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study","volume":"29","author":"de Simone","year":"2008","journal-title":"Eur Heart J"},{"key":"R13-2-20210207","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","article-title":"Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R14-2-20210207","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R15-2-20210207","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N Engl J Med"},{"key":"R16-2-20210207","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1527-5299.2007.07344.x","article-title":"Is heart failure more prevalent in patients with peripheral arterial disease? A meta-analysis","volume":"13","author":"Anand","year":"2007","journal-title":"Congest Heart Fail"},{"key":"R17-2-20210207","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCHEARTFAILURE.107.743146","article-title":"Death in heart failure: a community perspective","volume":"1","author":"Henkel","year":"2008","journal-title":"Circ Heart Fail"},{"key":"R18-2-20210207","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1023\/A:1009807918615","article-title":"Beta blockers in heart failure: issues in the management of individual patients","volume":"4","author":"Metra","year":"1999","journal-title":"Heart Fail Rev"},{"key":"R19-2-20210207","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cardfail.2007.01.009","article-title":"The incidence of ischemic stroke in chronic heart failure: a meta-analysis","volume":"13","author":"Witt","year":"2007","journal-title":"J Card Fail"},{"key":"R20-2-20210207","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"R22-2-20210207","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/eurheartj\/ehi166","article-title":"Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"R23-2-20210207","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N Engl J Med"},{"key":"R24-2-20210207","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10557-008-6142-7","article-title":"The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy","volume":"23","author":"Nodari","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"R25-2-20210207","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cardfail.2006.08.213","article-title":"Reducing the risk of sudden death in heart failure with beta-blockers","volume":"12","author":"Adamson","year":"2006","journal-title":"J Card Fail"},{"key":"R26-2-20210207","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.","volume":"372","author":"Gissi-HF Investigators, Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"R27-2-20210207","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9149(02)03301-5","article-title":"Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure","volume":"91","author":"Trichon","year":"2003","journal-title":"Am J Cardiol"},{"key":"R28-2-20210207","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/eurjhf\/hfq014","article-title":"Prognostic implications of functional mitral regurgitation according to the severity of the underlying chronic heart failure: a long-term outcome study","volume":"12","author":"Bursi","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R29-2-20210207","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1161\/CIRCULATIONAHA.108.818724","article-title":"REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) Study Group. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I\/II heart failure","volume":"120","author":"St John Sutton","year":"2009","journal-title":"Circulation"},{"key":"R30-2-20210207","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jacc.2009.03.077","article-title":"Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort","volume":"54","author":"Feldman","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R31-2-20210207","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","article-title":"Heart failure and chronic obstructive pulmonary disease: an ignored combination?","volume":"8","author":"Rutten","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R32-2-20210207","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejheart.2005.01.008","article-title":"Frequent noncardiac comorbities in patients with chronic heart failure","volume":"7","author":"Dahlstr\u00f6m","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R33-2-20210207","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/eurjhf\/hfq040","article-title":"Baseline characteristics and outcomes of patients with heart failure receiving bronchodilators in the CHARM programme","volume":"12","author":"Hawkins","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"R34-2-20210207","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1067\/mhj.2000.110282","article-title":"Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure","volume":"140","author":"Agostoni","year":"2000","journal-title":"Am Heart J"},{"key":"R35-2-20210207","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1161\/01.CIR.96.7.2221","article-title":"Lung function and exercise gas exchange in chronic heart failure","volume":"96","author":"Wasserman","year":"1997","journal-title":"Circulation"},{"key":"R36-2-20210207","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1152\/jappl.1996.80.2.623","article-title":"Contribution of PO2, P50, and Hb to changes in arteriovenous O2 content during exercise in heart failure","volume":"80","author":"Perego","year":"1996","journal-title":"J Appl Physiol"},{"key":"R37-2-20210207","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejheart.2003.10.003","article-title":"N-terminal pro-brain natriuretic peptide for discriminating between cardiac and noncardiac dyspnoea","volume":"6","author":"Nielsen","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"R38-2-20210207","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejheart.2007.03.001","article-title":"Right ventricular dysfunction as an independent predictor of short- and long-term mortality in patients with heart failure","volume":"9","author":"Kjaergaard","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R39-2-20210207","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"key":"R40-2-20210207","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/eurheartj\/ehi023","article-title":"Spironolactone improves lung diffusion in chronic heart failure","volume":"26","author":"Agostoni","year":"2005","journal-title":"Eur Heart J"},{"key":"R41-2-20210207","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ejheart.2007.04.006","article-title":"Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?","volume":"9","author":"Agostoni","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R42-2-20210207","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1378\/chest.114.2.411","article-title":"Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia","volume":"114","author":"Cazzola","year":"1998","journal-title":"Chest"},{"key":"R43-2-20210207","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/oxfordjournals.aje.a117647","article-title":"Respiratory illness, \u03b2-agonists, and risk of idiopathic dilated cardiomyopathy: the Washington, DC, Dilated Cardiomyopathy Study","volume":"142","author":"Coughlin","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R44-2-20210207","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2004.03.048","article-title":"Association between chronic heart failure and inhaled b-2-adrenoceptor agonists","volume":"148","author":"Au","year":"2004","journal-title":"Am Hart J"},{"key":"R45-2-20210207","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/hrt.2004.048314","article-title":"Sleep disordered breathing and its treatment in congestive heart failure","volume":"91","author":"Cormican","year":"2005","journal-title":"Heart"},{"key":"R46-2-20210207","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5664\/jcsm.26818","article-title":"The scoring of respiratory events in sleep: reliability and validity","volume":"3","author":"Redline","year":"2007","journal-title":"J Clin Sleep Med"},{"key":"R47-2-20210207","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","article-title":"Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients","volume":"9","author":"Oldenburg","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R48-2-20210207","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1164\/rccm.200607-927OC","article-title":"Fluid shift by lower body positive pressure increases pharyngeal resistance in healthy subjects","volume":"174","author":"Chiu","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"R49-2-20210207","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.pcad.2008.02.003","article-title":"Mechanisms of apnea","volume":"51","author":"Eckert","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"R50-2-20210207","doi-asserted-by":"crossref","first-page":"R1671","DOI":"10.1152\/ajpregu.00400.2007","article-title":"Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk","volume":"293","author":"Parati","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R51-2-20210207","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","article-title":"Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study","volume":"163","author":"Shahar","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R52-2-20210207","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jacc.2006.12.046","article-title":"Influence of obstructive sleep apnea on mortality in patients with heart failure","volume":"49","author":"Wang","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R53-2-20210207","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022479","article-title":"Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea","volume":"348","author":"Kaneko","year":"2003","journal-title":"N Engl J Med"},{"key":"R54-2-20210207","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N Engl J Med"},{"key":"R55-2-20210207","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1161\/CIRCULATIONAHA.106.683482","article-title":"Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP)","volume":"115","author":"Arzt","year":"2007","journal-title":"Circulation"},{"key":"R56-2-20210207","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1164\/ajrccm.164.4.9908114","article-title":"Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure","volume":"164","author":"Teschler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R57-2-20210207","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"R58-2-20210207","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jama.298.11.1312","article-title":"Prescribing amiodarone: an evidence-based review of clinical indications","volume":"298","author":"Vassallo","year":"2007","journal-title":"JAMA"},{"key":"R59-2-20210207","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archinte.161.7.996","article-title":"Risk factors for congestive heart failure in US men and women. NHANES I epidemiologic follow-up study","volume":"161","author":"He","year":"2001","journal-title":"Arch Intern Med"},{"key":"R60-2-20210207","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/j.jacc.2003.10.074","article-title":"The association of fasting glucose levels with congestive heart failure in diabetic adults \u2265 65 years. The Cardiovascular Health Study","volume":"43","author":"Barzilay","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R61-2-20210207","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"R62-2-20210207","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9149(01)02199-3","article-title":"Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure","volume":"89","author":"Guazzi","year":"2002","journal-title":"Am J Cardiol"},{"key":"R63-2-20210207","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2007.08.002","article-title":"Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"154","author":"Greenberg","year":"2007","journal-title":"Am Heart J"},{"key":"R64-2-20210207","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"R65-2-20210207","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0735-1097(01)01408-5","article-title":"Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction","volume":"38","author":"Dries","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R66-2-20210207","doi-asserted-by":"crossref","first-page":"113B","DOI":"10.1016\/j.amjcard.2006.11.013","article-title":"Diabetes mellitus and heart failure: epidemiology, mechanisms, and pharmacotherapy","volume":"99","author":"Masoudi","year":"2007","journal-title":"Am J Cardiol"},{"key":"R67-2-20210207","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1388-9842(03)00151-X","article-title":"Efficacy and tolerability of the long-term administration of carvedilol in patients with chronic heart failure with and without concomitant diabetes mellitus","volume":"5","author":"Nodari","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"R68-2-20210207","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/bmj.39314.620174.80","article-title":"Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic review","volume":"335","author":"Eurich","year":"2007","journal-title":"BMJ"},{"key":"R69-2-20210207","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/diacare.27.1.256","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"27","author":"Nesto","year":"2004","journal-title":"Diabetes Care"},{"key":"R70-2-20210207","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1056\/NEJM199006143222403","article-title":"Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease","volume":"322","author":"Pekkanen","year":"1990","journal-title":"N Engl J Med"},{"key":"R71-2-20210207","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1054\/jcaf.2002.0804216","article-title":"Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure","volume":"8","author":"Horwich","year":"2002","journal-title":"J Card Fail"},{"key":"R72-2-20210207","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jacc.2007.04.050","article-title":"Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure","volume":"50","author":"Zac\u00e0","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R73-2-20210207","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jacc.2007.10.009","article-title":"Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy","volume":"51","author":"Ramasubbu","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R74-2-20210207","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"R75-2-20210207","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jacc.2009.06.041","article-title":"Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)","volume":"54","author":"Cleland","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R76-2-20210207","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"R77-2-20210207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archinte.165.1.55","article-title":"The obesity paradox: body mass index and outcomes in patients with heart failure","volume":"165","author":"Curtis","year":"2005","journal-title":"Arch Intern Med"},{"key":"R78-2-20210207","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/S0735-1097(01)01627-8","article-title":"Renal function: the Cinderella of cardiovascular risk profile","volume":"38","author":"Ruilope","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R79-2-20210207","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000143547.55093.17","article-title":"The clinical challenge of cardiorenal syndrome","volume":"110","author":"Shlipak","year":"2004","journal-title":"Circulation"},{"key":"R80-2-20210207","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/j.jacc.2005.11.084","article-title":"Renal impairment and outcomes in heart failure: systematic review and meta-analysis","volume":"47","author":"Smith","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R81-2-20210207","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardfail.2007.04.008","article-title":"Worsening renal function and prognosis in heart failure: systematic review and meta-analysis","volume":"13","author":"Damman","year":"2007","journal-title":"J Card Fail"},{"key":"R82-2-20210207","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejheart.2008.01.011","article-title":"Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance","volume":"10","author":"Metra","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"R83-2-20210207","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jacc.2007.08.072","article-title":"Cardiorenal interactions: insights from the ESCAPE trial","volume":"51","author":"Nohria","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R84-2-20210207","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"New Engl J Med"},{"issue":"Suppl F","key":"R85-2-20210207","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/eurheartj\/8.suppl_F.23","article-title":"Epidemiology and prevention of cardiac failure: Framingham Study insights","volume":"8","author":"Kannel","year":"1987","journal-title":"Eur Heart J"},{"key":"R86-2-20210207","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10741-008-9088-8","article-title":"Heart failure and anemia: mechanisms and pathophysiology","volume":"13","author":"Anand","year":"2008","journal-title":"Heart Fail Rev"},{"key":"R87-2-20210207","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10741-008-9085-y","article-title":"Approaches to the treatment of anaemia in patients with chronic heart failure","volume":"13","author":"Murphy","year":"2008","journal-title":"Heart Fail Rev"},{"key":"R89-2-20210207","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00415-003-0249-3","article-title":"Cognitive impairment: a key feature of congestive heart failure in the elderly","volume":"250","author":"Trojano","year":"2003","journal-title":"J Neurol"},{"key":"R90-2-20210207","first-page":"27","article-title":"Cardiogenic dementia.","volume":"1","year":"1977","journal-title":"Lancet"},{"key":"R91-2-20210207","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejheart.2006.11.001","article-title":"Cognitive impairment in heart failure: a systematic review of the literature","volume":"9","author":"Vogels","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R92-2-20210207","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cardfail.2005.03.006","article-title":"Depression and anxiety in heart failure","volume":"11","author":"Konstam","year":"2005","journal-title":"J Card Fail"},{"key":"R93-2-20210207","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","article-title":"Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure","volume":"161","author":"Jiang","year":"2001","journal-title":"Arch Intern Med"},{"key":"R94-2-20210207","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10741-007-9058-6","article-title":"Treatment of depression in patients with congestive heart failure","volume":"14","author":"Shapiro","year":"2009","journal-title":"Heart Fail Rev"},{"issue":"Suppl 1","key":"R95-2-20210207","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1600-0838.2006.00520.x","article-title":"Evidence for prescribing exercise as therapy in chronic disease","volume":"16","author":"Pedersen","year":"2006","journal-title":"Scand J Med Sci Sports"},{"issue":"Suppl 1","key":"R96-2-20210207","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1007\/s10067-006-0203-8","article-title":"Update on guidelines for the treatment of chronic musculoskeletal pain","volume":"25","author":"Schnitzer","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R97-2-20210207","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1136\/bmj.330.7504.1370","article-title":"Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or nonsteroidal anti-inflammatory drugs: population based study","volume":"330","author":"Hudson","year":"2005","journal-title":"BMJ"},{"key":"R98-2-20210207","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.108.784009","article-title":"Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16 294 patients","volume":"118","author":"van Diepen","year":"2008","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01244665-201102000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:18:32Z","timestamp":1786371512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01244665-201102000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2459\/jcm.0b013e32834058d1","relation":{},"ISSN":["1558-2027"],"issn-type":[{"value":"1558-2027","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}